Global Uveitis Treatment Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Uveitis Treatment Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Forecast 2024-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 5888962

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Uveitis Treatment Market size was estimated at USD 724.65 million in 2023, USD 783.24 million in 2024, and is expected to grow at a CAGR of 8.48% to reach USD 1,281.23 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Uveitis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Uveitis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Uveitis Treatment Market, highlighting leading vendors and their innovative profiles. These include Accutome, Inc., Ajanta Pharma Ltd., Alcon Vision LLC, Allergan PLC, Amorphex Therapeutics Holdings, Inc., Appasamy Ocular Device Pvt Ltd., Astellas Pharma Inc., Bausch & Lomb Incorporated, Bayer AG, Cipla Ltd., Entod Pharmaceuticals Ltd., EyePoint Pharmaceuticals, Inc., Fera Pharmaceuticals, His Eyeness Ophthalmics Pvt Ltd., Intas Pharmaceuticals Ltd., J B Chemicals And Pharmaceuticals Ltd., Kubota Vision Inc., Merck & Co. Inc., Micro Labs Ltd., Nidek Co Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sunways India Pvt Ltd., and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Uveitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
- Analgesics
- Antibiotics
- Antifungal
- Antivirals
- Corticosteroids
- Cycloplegic Agents
- Immunosuppressant
- Monoclonal Antibodies
Disease Type
- Anterior Uveitis
- Intermediate Uveitis
- Panuveitis
- Posterior Uveitis
Cause
- Infectious
- Noninfectious
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Uveitis Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Uveitis Treatment Market?
What are the technology trends and regulatory frameworks in the Uveitis Treatment Market?
What is the market share of the leading vendors in the Uveitis Treatment Market?
Which modes and strategic moves are suitable for entering the Uveitis Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Uveitis Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising aging population and increasing prevalence of chronic eye disorders
5.1.1.2. Advancement in diagnostic techniques for imaging uveitis
5.1.1.3. Technical improvement in drug delivery methods
5.1.2. Restraints
5.1.2.1. Long-term treatment and huge treatment costs
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for innovative treatment therapies
5.1.3.2. Emergence of telemedicine and remote monitoring of patients
5.1.4. Challenges
5.1.4.1. Side-effects associated with the usage of systemic immunosuppressive medications
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Uveitis Treatment Market, by Treatment Type

6.1. Introduction
6.2. Analgesics
6.3. Antibiotics
6.4. Antifungal
6.5. Antivirals
6.6. Corticosteroids
6.7. Cycloplegic Agents
6.8. Immunosuppressant
6.9. Monoclonal Antibodies

7. Uveitis Treatment Market, by Disease Type

7.1. Introduction
7.2. Anterior Uveitis
7.3. Intermediate Uveitis
7.4. Panuveitis
7.5. Posterior Uveitis

8. Uveitis Treatment Market, by Cause

8.1. Introduction
8.2. Infectious
8.3. Noninfectious

9. Uveitis Treatment Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Uveitis Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Uveitis Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Uveitis Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Accutome, Inc.
14.1.2. Ajanta Pharma Ltd.
14.1.3. Alcon Vision LLC
14.1.4. Allergan PLC
14.1.5. Amorphex Therapeutics Holdings, Inc.
14.1.6. Appasamy Ocular Device Pvt Ltd.
14.1.7. Astellas Pharma Inc.
14.1.8. Bausch & Lomb Incorporated
14.1.9. Bayer AG
14.1.10. Cipla Ltd.
14.1.11. Entod Pharmaceuticals Ltd.
14.1.12. EyePoint Pharmaceuticals, Inc.
14.1.13. Fera Pharmaceuticals
14.1.14. His Eyeness Ophthalmics Pvt Ltd.
14.1.15. Intas Pharmaceuticals Ltd.
14.1.16. J B Chemicals And Pharmaceuticals Ltd.
14.1.17. Kubota Vision Inc.
14.1.18. Merck & Co. Inc.
14.1.19. Micro Labs Ltd.
14.1.20. Nidek Co Ltd.
14.1.21. Novartis AG
14.1.22. Pfizer Inc.
14.1.23. Sun Pharmaceutical Industries Ltd.
14.1.24. Sunways India Pvt Ltd.
14.1.25. Teva Pharmaceutical Industries Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. UVEITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. UVEITIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UVEITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. UVEITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. UVEITIS TREATMENT MARKET DYNAMICS
FIGURE 7. UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 10. UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2023 VS 2030 (%)
FIGURE 12. UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. UVEITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. UVEITIS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. UVEITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. UVEITIS TREATMENT MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. UVEITIS TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. UVEITIS TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 15. UVEITIS TREATMENT MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. UVEITIS TREATMENT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. UVEITIS TREATMENT MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 20. UVEITIS TREATMENT MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. UVEITIS TREATMENT MARKET SIZE, BY NONINFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 42. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 64. CHINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 68. INDIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 137. ITALY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 153. POLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 157. QATAR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 195. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 196. UVEITIS TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

Accutome, Inc.
Ajanta Pharma Ltd.
Alcon Vision LLC
Allergan PLC
Amorphex Therapeutics Holdings, Inc.
Appasamy Ocular Device Pvt Ltd.
Astellas Pharma Inc.
Bausch & Lomb Incorporated
Bayer AG
Cipla Ltd.
Entod Pharmaceuticals Ltd.
EyePoint Pharmaceuticals, Inc.
Fera Pharmaceuticals
His Eyeness Ophthalmics Pvt Ltd.
Intas Pharmaceuticals Ltd.
J B Chemicals And Pharmaceuticals Ltd.
Kubota Vision Inc.
Merck & Co. Inc.
Micro Labs Ltd.
Nidek Co Ltd.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Sunways India Pvt Ltd.
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 783.24 Million
Forecasted Market Value ( USD ) by 2030	$ 1281.23 Million
Compound Annual Growth Rate	8.4%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Uveitis Drugs Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030

Uveitis Market Insight, Epidemiology and Market Forecast - 2034

Uveitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Uveitis Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F